Edition:
United States

Medivir AB (MVIRb.ST)

MVIRb.ST on Stockholm Stock Exchange

57.75SEK
28 Jul 2016
Change (% chg)

-- (--)
Prev Close
57.75kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
60,955
52-wk High
94.75kr
52-wk Low
46.90kr

MVIRb.ST

Chart for MVIRb.ST

About

Medivir AB is a Sweden-based pharmaceutical company engaged in the research, development and sale of drugs against widespread diseases, with protease and polymerase as its target enzymes. The Company’s research focuses on developing small molecule pharmaceuticals, primarily against infectious diseases caused by viruses. The... (more)

Overall

Beta: 1.31
Market Cap(Mil.): kr1,535.45
Shares Outstanding(Mil.): 26.36
Dividend: --
Yield (%): --

Financials

  MVIRb.ST Industry Sector
P/E (TTM): -- 42.74 36.62
EPS (TTM): -1.23 -- --
ROI: -2.24 -9.63 14.52
ROE: -2.25 -9.94 15.68

BRIEF-Medivir makes 40.5 mln SEK loss after tax in Q1

* Medivir q1 net turnover totalled sek 75.0 million (215.9 m), of which sek 18.1 million Source text for Eikon: Further company coverage: [ ] (Reporting By Johan Ahlander)

Apr 28 2016

BRIEF-Medivir swings to a Q4 loss 

* Q4 net turnover totalled SEK 84.7 million (377.0 m), SEK 31.1 million (220.1 m) of which comprised royalties for simeprevir.

Feb 18 2016

BRIEF-HealthInvest increases stake in Medivir to 11 pct of shares 

* HealthInvest Partners AB increases stake to 11.1 pct in Medivir Further company coverage:

Feb 11 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.